Value of protocols of alternating chemotherapy versus melphalan-prednisone during the induction phase of stage IIi myelomas. Critical review
Paule, B.; Medicis, P.; Clerc, D.; Bennet, P.; Bisson, M.; Massias, P.
Revue du Rhumatisme et des Maladies Osteo-Articulaires 54(12): 827-832
1987
ISSN/ISBN: 0035-2659 PMID: 3324290 Document Number: 291988
Document emailed within 1 workday
Related Documents
Cigolari, S.; Curcio, C.; Maiorino, A.; Sessa, R.; Cioffi, A.; Massimo, M. 2003: Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study Anticancer Research 23(2c): 1803-1809Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Takagi, T.; Sakai, C.; Oguro, M. 1993: Alternating CHOP-MEVP chemotherapy for advanced-stage, intermediate- and high-grade non-Hodgkin's lymphomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2191-2194
Bonadonna, G.; Valagussa, P.; Santoro, A. 1986: Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results Annals of Internal Medicine 104(6): 739-746
Levin, M.; Chokas, W. 1987: Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone New England Journal of Medicine 317(18): 1155-1156
Brun, B.; Kuentz, M.; Man, N.G.; Feuilhade, F.; Bierling, P.; Vernant, J.P.; Farcet, J.P.; Cordonnier, C.; Reyes, F.; Dreyfus, B.; Rochant, H. 1983: Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases Presse Medicale 12(19): 1205-1210
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Willenborg, D.O.; Fordham, S.; Bernard, C.C.; Cowden, W.B.; Ramshaw, I.A. 1996: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis Journal of Immunology 157(8): 3223-3227
Kodama, M.; Kodama, T. 1981: Adolescence, a critical stage for the genesis of female cancers (review) Anticancer Research 1(2): 93-99
Komarnicki, M.; Balcerzak, A.; Górski, P.; Pawlak, L.; Hansz, J. 1994: Treatment outcome of advanced Hodgkin's disease based on using an alternating program ChLVPP (chlorambucil, vinblastine, procarbazine, prednisone) and ABV (doxorubicin, bleomycin, vinblastine) Acta Haematologica Polonica 25(4): 363-368
Alexanian, R.; Migliore, P.J. 1970: Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy Journal of Laboratory and Clinical Medicine 75(2): 225-233
Leal-Leal, C.A.; Asencio-López, L.; Higuera-Calleja, J.ús.; Bernal-Moreno, M.; Bosch-Canto, V.; Chávez-Pacheco, J.; Isaac-Otero, G.; Beck-Popovic, M. 2016: Globe Salvage with Intra-Arterial Topotecan-Melphalan Chemotherapy in Children with a Single Eye Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 68(3): 137-142
Kodaira, T.; Fuwa, N.; Kamata, M.; Furutani, K.; Tachibana, H.; Yamazaki, T. 2006: Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma Anticancer Research 26(1b): 471-478
Abeloff, M.D.; Ettinger, D.S. 1977: Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy Cancer Treatment Reports 61(9): 1685-1689
Sobecks, R.M.; Vogelzang, N.J. 1999: High-dose chemotherapy with autologous stem-cell support for germ cell tumors: a critical review Seminars in Oncology 26(1): 106-118
Geva, E.; Yovel, I.; Lessing, J.B.; Yaron, Y.; Botchan, A.; David, M.P.; Peyser, M.R.; Amit, A. 1993: Comparison of ovulation induction protocols for in vitro fertilization Harefuah 125(5-6): 129-133; 192
Lai, S.L.; Perng, R.P. 2000: Combination versus alternating chemotherapy in small-cell lung cancer Zhonghua Yi Xue Za Zhi 63(7): 513-520
Kyo, T.; Dohy, H. 1988: Treatment of acute non-lymphocytic leukemia with alternating non-cross resistant chemotherapy Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(8): 1641-1652
Markman, M.; Abeloff, M.D.; Berkman, A.W.; Waterfield, W.C. 1985: Intensive alternating chemotherapy regimen in small cell carcinoma of the lung Cancer Treatment Reports 69(2): 161-166
Brusamolino, E.; Lazzarino, M.; Morra, E.; Inverardi, D.; Merante, S.; Castelli, G.; Canevari, A.; Dornini, G.; Bernasconi, C. 1989: Combination chemotherapy with alternating MOPP-ABVD in advanced Hodgkin's disease Haematologica 74(2): 173-179